Cargando…
Cellular and animal models for high-throughput screening of therapeutic agents for the treatment of the diseases of the elderly in general and Alzheimer’s disease in particular(†)
It is currently thought that the dementia of Alzheimer’s disease is due to the neurotoxicity of the deposits or aggregates of amyloid-β (Aβ) in the extracellular space of the cerebral cortex. This model has been widely criticized because there is a poor correlation between deposits and dementia. Oth...
Autor principal: | Holtzman, Jordan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651961/ https://www.ncbi.nlm.nih.gov/pubmed/23717280 http://dx.doi.org/10.3389/fphar.2013.00059 |
Ejemplares similares
-
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019) -
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
por: Beggiato, Sarah, et al.
Publicado: (2019) -
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023) -
The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect
por: Xian Bo, Shang, et al.
Publicado: (2022) -
Sirtuin Modulators in Cellular and Animal Models of Human Diseases
por: Hong, Jun Young, et al.
Publicado: (2021)